skip banner navigation
National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Superior Vena Cava Syndrome (PDQ®)
Patient VersionHealth Professional VersionEn EspaņolLast Modified: 01/23/2003




Introduction






Overview






Causes






Diagnosis






Treatment






Social Considerations






Superior Vena Cava Syndrome Occurring in Children






Questions or Comments About This Summary






To Learn More






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Dictionary

Funding Opportunities

NCI Publications

NCI Calendar

Español
NCI Highlights
NCI Annual Progress Report on Cancer Research 2003

Women, Tobacco and Cancer: Agenda for 21st Century

Past Highlights
Need Help?
Introduction

This patient summary on superior vena cava syndrome is adapted from a summary written for health professionals by cancer experts. This and other credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials is available from the National Cancer Institute. Superior vena cava syndrome is a collection of symptoms that can occur in patients who have lung cancer, non-Hodgkin's lymphoma or other cancers. It also can occur from noncancer causes. Although serious when it occurs in adults, this syndrome is life threatening in children. This brief summary describes superior vena cava syndrome and its treatment.

Back to TopBack to Top

Next Section >

skip footer navigation

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health FirstGov.gov